Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2011 Jan;30(1):69-72.
doi: 10.1097/INF.0b013e3181f2da06.

Safety and immunogenicity of a booster dose of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine coadministered with DTPw-HBV/Hib and poliovirus vaccines

Nancy Bermal  1 , Leszek Szenborn, Alberto Edison, Marina Hernandez, Jerzy Pejcz, Ewa Majda-Stanislawska, Salvacion Gatchalian, Aurélie Fanic, Ilse Dieussaert, Lode Schuerman
Affiliations
Clinical Trial

Safety and immunogenicity of a booster dose of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine coadministered with DTPw-HBV/Hib and poliovirus vaccines

Nancy Bermal et al. Pediatr Infect Dis J. 2011 Jan.

Abstract

The safety and reactogenicity profiles of the 10-valent pneumococcal conjugate vaccine, PHiD-CV, and 7vCRM were comparable within the Philippines and Poland when coadministered as a booster dose with DTPw-HBV/Hib and poliovirus vaccines to toddlers primed with the same vaccines. Robust immune responses for all 10 vaccine pneumococcal serotypes and protein D following PHiD-CV booster vaccination were indicative of effective priming.

Trial registration: ClinicalTrials.gov NCT00547248.

PubMed Disclaimer

Publication types

MeSH terms

Substances

Associated data